Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

Association between [ 68 Ga]NODAGA-RGDyK uptake and dynamics of angiogenesis in a human cell-based 3D model.

Grönman M., Moisio O., Li XG., Toimela T., Huttala O., Heinonen T.

Laboratory Study on Hip, published in Mol Biol Rep (2021) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Mol Biol Rep (2021)
Country
Netherlands
Reported sample size
—
Source database
PubMed
PMID
34213709
PMCID
PMC8318966
DOI
10.1007/s11033-021-06513-8
Citations
2

Abstract (original English)

Radiolabeled RGD peptides targeting expression of α v β 3 integrin have been applied to in vivo imaging of angiogenesis. However, there is a need for more information on the quantitative relationships between RGD peptide uptake and the dynamics of angiogenesis. In this study, we sought to measure the binding of [ 68 Ga]NODAGA-RGDyK to α v β 3 integrin in a human cell-based three-dimensional (3D) in vitro model of angiogenesis, and to compare the level of binding with the amount of angiogenesis. Experiments were conducted using a human cell-based 3D model of angiogenesis consisting of co-culture of human adipose stem cells (hASCs) and of human umbilical vein endothelial cells (HUVECs). Angiogenesis was induced with four concentrations (25%, 50%, 75%, and 100%) of growth factor cocktail resulting in a gradual increase in the density of the tubule network. Cultures were incubated with [ 68 Ga]NODAGA-RGDyK for 90 min at 37 °C, and binding of radioactivity was measured by gamma counting and digital autoradiography. The results revealed that tracer binding increased gradually with neovasculature density. In comparison with vessels induced with a growth factor concentration of 25%, the uptake of [ 68 Ga]NODAGA-RGDyK was higher at concentrations of 75% and 100%, and correlated with the amount of neovasculature, as determined by visual evaluation of histological staining. Uptake of [ 68

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AcetatesAngiogenesis Inducing AgentsCell Culture Techniques, Three DimensionalCell Line, TumorEndothelial CellsGallium RadioisotopesHeterocyclic Compounds, 1-RingHumansIntegrin alphaVbeta3Isotope Labeling

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research